This compound is a pharmaceutical intermediate designed for impurity synthesis, featuring a pyrrolidine carboxylate structure with an aminoimidazopyrazine moiety. It is primarily used as a reference standard or building block in pharmaceutical research and manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 2170801-87-1
(S)-Benzyl 2-(8-chloroimidazo[1,5-a]pyrazin-3-yl)pyrrolidine-1-carboxylate
pharmaceutical raw material
Diazepam N-oxide
pharmaceutical intermediate
2H-Benzimidazol-2-one, 1,3-dihydro-5-chloro-1-methyl-3-phenyl-
pharmaceutical intermediate
4-{[6-Chloro-2-(4-cyanoanilino)pyrimidin-4-yl]oxy}-3,5-dimethylbenzonitrile
pharmaceutical intermediate
Carbamic acid, cyano-, methyl ester
pharmaceutical intermediate
Fmoc-Ile-Aib-OH
pharmaceutical intermediate
((3aS,5R,6S,6aS)-6-(benzyloxy)-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)(morpholino)methanone
pharmaceutical intermediate
((((E)-2-((2R,3R,4R,5R)-3-(((2-CYANOETHOXY)(DIISOPROPYLAMINO)PHOSPHINO)OXY)-5-(2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)-4-METHOXYTETRAHYDROFURAN-2-YL)VINYL)PHOSPHORYL)BIS(OXY))BIS(METHYLENE) BIS(2,2-DIMETHYLPROPANOATE)
pharmaceutical intermediate
benzyl (2S)-2-(8-aminoimidazo[1,5-a]pyrazin-3-yl)pyrrolidine-1-carboxylate
WJIKKVMDANXFJV-AWEZNQCLSA-N
C1C[C@H](N(C1)C(=O)OCC2=CC=CC=C2)C3=NC=C4N3C=CN=C4N
—